Journal
NEOPLASMA
Volume 57, Issue 3, Pages 228-233Publisher
VEDA, SLOVAK ACAD SCIENCES
DOI: 10.4149/neo_2010_03_228
Keywords
SFRP 1; DNA methylation; biomarker; non-small cell lung cancer
Categories
Ask authors/readers for more resources
Epigenetic silencing of secreted frizzled-related protein (SFRP) genes, antagonists of the WNT pathway, contributes to the pathogenesis of several cancers including non-small cell lung cancer (NSCLC). We hypothesize that methylation analysis of SFRPs family could improve their use as a panel of biomarkers for diagnosing and staging of NSCLC in China. The expression of four SFRP members (SFRP1, 2, 4, and 5) in NSCLC samples was screened by RT-PCR and quantitative real-time PCR. Only SFRP I was significantly downregulated in NSCLC, as compared to adjacent normal tissues and benign pulmonary disease tissues (P=0.006). Promoter hypermethylation of SFRP1 was found in 32.1% (25/78) NSCLC specimens and was closely correlated with loss of expression, besides SFRP I hypermethylation was associated with lymph metastasis (P=0.039) and disease progression within one year (P=0.027). Furthermore, methylated SFRP1 was detected in 28.2% (22/78) of plasma samples from NSCLC patients while only 4% (2/50) in cancer-free controls, and the concordance of SFRP I methylation status in tumor tissues and corresponding plasmas was satisfactory (P<0.001). In conclusion, epigenetic inactivation of SFRP I is a common event contributing to lung carcinogenesis and maybe used as a potential biomarker for NSCLC in Chinese population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available